Advance Inc.

CNS Protein Therapeutics Completes Name Change to Amarantus Therapeutics, Appoints New CEO Martin D. Cleary.
Heart Disease Weekly; 11/15/2009; 1142 words; ...About Amarantus Therapeutics, Inc. Amarantus Therapeutics, Inc., formerly known as CNS Protein...million Series A that it will use to advance its lead programs in Parkinson...Vaccines, Amarantus Therapeutics Inc. This article was prepared by...

Thermo Fisher Scientific Launches New Biomarker Test in Europe to Rapidly Diagnose Heart Attack.
Heart Disease Weekly; 11/15/2009; 976 words; ...also Thermo Fisher Scientific Inc.). "We acquired B.R.A...Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world...to customers and continuously advance our technologies to accelerate...Actions, Thermo Fisher Scientific Inc. This article was prepared by...

Michael Eisner's Vuguru and Rogers Media Strike Investment and Distribution Deal.
Entertainment Business Newsweekly; 11/15/2009; 1519 words; ...Foreign Body, a prequel web-series released in advance of best-selling author Robin Cook's latest...Glenn Martin, DDS) and The Topps Company, Inc. About Rogers Media Inc. Rogers Media Inc., a division of Rogers Communications Inc...

Impax Pharmaceuticals Initiates Second Phase III Trial of IPX066 in Parkinson's Disease.
Medical Letter on the CDC & FDA; 11/15/2009; 1468 words; ...division of Impax Laboratories, Inc. (NASDAQ:IPXL), announced...see also Impax Laboratories, Inc.). Michael Nestor, divisional...quickly as possible." About the ADVANCE-PD Phase III Study The ADVANCE...About Impax Laboratories, Inc. Impax Laboratories, Inc...

Findings from A. Onat and co-researchers advance knowledge in heart disease.
Heart Disease Weekly; 11/15/2009; 934 words; ...34335 Istanbul, Turkey. The publisher of the journal Diabetic Medicine can be contacted at: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA. Keywords: Turkey, Istanbul, Cardiology, Coronary Heart Disease...